{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1142.23",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "SAMHSA Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-05-22"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2016-09-09"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.23",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1142.23"
    }
  ],
  "version" : "20160909",
  "name" : "C2SHIVAIDSInformationSensitivity",
  "title" : "C2S HIV/AIDS Information Sensitivity",
  "status" : "active",
  "experimental" : false,
  "date" : "2016-09-09T01:00:03-04:00",
  "publisher" : "SAMHSA Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This value set is intended for use by organizations exchanging personally identifiable protected health information to perform data segmentation based on personal patient privacy preferences in the event individuals choose not to share their sensitive information. These value sets are drawn from terminology standards required for Meaningful Use certification of Electronic Health Record (EHR) systems. This type of reference information is intended to assist the implementers of interoperable EHR systems and health information exchange systems to identify and create business rules regarding the exchange and use of information identified as sensitive by jurisdictional privacy policies (e.g. state policies, 43 CFR Part 2, Title 38).),(Data Element Scope: This value set is intended to apply to disorders related to HIV/AIDS),(Inclusion Criteria: SNOMED CT codes gleaned from the SNOMED CT to ICD-10 map that is released on 31 January and 31 July of each calendar year as a derivative of SNOMED CT International.),(Exclusion Criteria: Complete set of current LOINC, RxNorm and HCPCS and CPT)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "concept" : [
          {
            "code" : "0575F",
            "display" : "Hiv rna control plan of care, documented (hiv)"
          },
          {
            "code" : "3292F",
            "display" : "Hiv testing ordered or documented and reviewed during the first or second prenatal visit (pre-cr)"
          },
          {
            "code" : "3490F",
            "display" : "History of aids-defining condition (hiv)"
          },
          {
            "code" : "3491F",
            "display" : "Hiv indeterminate (infants of undetermined hiv status born of hiv-infected mothers) (hiv)"
          },
          {
            "code" : "3492F",
            "display" : "History of nadir cd4+ cell count <350 cells/mm (hiv)"
          },
          {
            "code" : "3493F",
            "display" : "No history of nadir cd4+ cell count <350 cells/mmand no history of aids-defining condition (hiv)"
          },
          {
            "code" : "3494F",
            "display" : "Cd4+ cell count <200 cells/mm (hiv)"
          },
          {
            "code" : "3495F",
            "display" : "Cd4+ cell count 200 - 499 cells/mm (hiv)"
          },
          {
            "code" : "3496F",
            "display" : "Cd4+ cell count =500 cells/mm (hiv)"
          },
          {
            "code" : "3497F",
            "display" : "Cd4+ cell percentage <15% (hiv)"
          },
          {
            "code" : "3498F",
            "display" : "Cd4+ cell percentage >/=15% (hiv)"
          },
          {
            "code" : "3500F",
            "display" : "Cd4+ cell count or cd4+ cell percentage documented as performed (hiv)"
          },
          {
            "code" : "3502F",
            "display" : "Hiv rna viral load below limits of quantification (hiv)"
          },
          {
            "code" : "3503F",
            "display" : "Hiv rna viral load not below limits of quantification (hiv)"
          },
          {
            "code" : "3510F",
            "display" : "Documentation that tuberculosis (tb) screening test performed and results interpreted (hiv) (ibd)"
          },
          {
            "code" : "3511F",
            "display" : "Chlamydia and gonorrhea screenings documented as performed (hiv)"
          },
          {
            "code" : "3512F",
            "display" : "Syphilis screening documented as performed (hiv)"
          },
          {
            "code" : "3513F",
            "display" : "Hepatitis b screening documented as performed (hiv)"
          },
          {
            "code" : "3514F",
            "display" : "Hepatitis c screening documented as performed (hiv)"
          },
          {
            "code" : "3515F",
            "display" : "Patient has documented immunity to hepatitis c (hiv)"
          },
          {
            "code" : "4149F",
            "display" : "Hepatitis b vaccine injection administered or previously received (hep-c, hiv) (ibd)"
          },
          {
            "code" : "4270F",
            "display" : "Patient receiving potent antiretroviral therapy for 6 months or longer (hiv)"
          },
          {
            "code" : "4271F",
            "display" : "Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (hiv)"
          },
          {
            "code" : "4274F",
            "display" : "Influenza immunization administered or previously received (hiv) (p-esrd)"
          },
          {
            "code" : "4276F",
            "display" : "Potent antiretroviral therapy prescribed (hiv)"
          },
          {
            "code" : "4279F",
            "display" : "Pneumocystis jiroveci pneumonia prophylaxis prescribed (hiv)"
          },
          {
            "code" : "4280F",
            "display" : "Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count or percentage (hiv)"
          },
          {
            "code" : "4290F",
            "display" : "Patient screened for injection drug use (hiv)"
          },
          {
            "code" : "4293F",
            "display" : "Patient screened for high-risk sexual behavior (hiv)"
          },
          {
            "code" : "86689",
            "display" : "Confirmation test for antibody to Human T-cell lymphotropic virus (HTLV) or HIV"
          },
          {
            "code" : "86701",
            "display" : "Analysis for antibody to HIV -1 virus"
          },
          {
            "code" : "86702",
            "display" : "Analysis for antibody to HIV-2 virus"
          },
          {
            "code" : "86703",
            "display" : "Analysis for antibody to HIV-1 and HIV-2 virus"
          },
          {
            "code" : "87389",
            "display" : "Detection test for HIV-1 and HIV-2"
          },
          {
            "code" : "87390",
            "display" : "Detection test for HIV-1"
          },
          {
            "code" : "87391",
            "display" : "Detection test for HIV-2"
          },
          {
            "code" : "87534",
            "display" : "Detection test for HIV-1 virus"
          },
          {
            "code" : "87535",
            "display" : "Detection test for HIV-1 virus"
          },
          {
            "code" : "87536",
            "display" : "Detection test for HIV-1 virus"
          },
          {
            "code" : "87537",
            "display" : "Detection test for HIV-2 virus"
          },
          {
            "code" : "87538",
            "display" : "Detection test for HIV-2 virus"
          },
          {
            "code" : "87539",
            "display" : "Detection test for HIV-2 virus"
          },
          {
            "code" : "87900",
            "display" : "Infectious agent drug susceptibility analysis"
          },
          {
            "code" : "87901",
            "display" : "Analysis test for HIV-1 virus"
          },
          {
            "code" : "87903",
            "display" : "Analysis test for HIV-1 virus"
          },
          {
            "code" : "87904",
            "display" : "Analysis test for HIV-1 virus"
          },
          {
            "code" : "87906",
            "display" : "Analysis test for HIV-1 virus"
          },
          {
            "code" : "G0432",
            "display" : "Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening"
          },
          {
            "code" : "G0433",
            "display" : "Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening"
          },
          {
            "code" : "G0435",
            "display" : "Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening"
          },
          {
            "code" : "G8491",
            "display" : "I intend to report the hiv/aids measures group"
          },
          {
            "code" : "G8500",
            "display" : "All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient"
          },
          {
            "code" : "S3645",
            "display" : "Hiv-1 antibody testing of oral mucosal transudate"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:26e069ab-57d5-44b8-bf19-5ce1569bffcd",
    "timestamp" : "2024-06-14T11:39:05-04:00",
    "total" : 51,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "0575F",
        "display" : "Hiv rna control plan of care, documented (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3292F",
        "display" : "Hiv testing ordered or documented and reviewed during the first or second prenatal visit (pre-cr)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3490F",
        "display" : "History of aids-defining condition (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3491F",
        "display" : "Hiv indeterminate (infants of undetermined hiv status born of hiv-infected mothers) (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3492F",
        "display" : "History of nadir cd4+ cell count <350 cells/mm (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3493F",
        "display" : "No history of nadir cd4+ cell count <350 cells/mmand no history of aids-defining condition (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3494F",
        "display" : "Cd4+ cell count <200 cells/mm3 (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3495F",
        "display" : "Cd4+ cell count 200 - 499 cells/mm3 (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3496F",
        "display" : "Cd4+ cell count >=500 cells/mm3 (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3497F",
        "display" : "Cd4+ cell percentage <15% (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3498F",
        "display" : "Cd4+ cell percentage >/=15% (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3500F",
        "display" : "Cd4+ cell count or cd4+ cell percentage documented as performed (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3502F",
        "display" : "Hiv rna viral load below limits of quantification (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3503F",
        "display" : "Hiv rna viral load not below limits of quantification (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3510F",
        "display" : "Documentation that tuberculosis (tb) screening test performed and results interpreted (hiv) (ibd)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3511F",
        "display" : "Chlamydia and gonorrhea screenings documented as performed (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3512F",
        "display" : "Syphilis screening documented as performed (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3513F",
        "display" : "Hepatitis b screening documented as performed (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3514F",
        "display" : "Hepatitis c screening documented as performed (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "3515F",
        "display" : "Patient has documented immunity to hepatitis c (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4149F",
        "display" : "Hepatitis b vaccine injection administered or previously received (hep-c, hiv) (ibd)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4270F",
        "display" : "Patient receiving potent antiretroviral therapy for 6 months or longer (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4271F",
        "display" : "Patient receiving potent antiretroviral therapy for less than 6 months or not receiving potent antiretroviral therapy (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4274F",
        "display" : "Influenza immunization administered or previously received (hiv) (p-esrd)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4276F",
        "display" : "Potent antiretroviral therapy prescribed (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4279F",
        "display" : "Pneumocystis jiroveci pneumonia prophylaxis prescribed (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4280F",
        "display" : "Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count or percentage (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4290F",
        "display" : "Patient screened for injection drug use (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "4293F",
        "display" : "Patient screened for high-risk sexual behavior (hiv)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "86689",
        "display" : "Confirmation test for antibody to Human T-cell lymphotropic virus (HTLV) or HIV"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "86701",
        "display" : "Analysis for antibody to HIV -1 virus"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "86702",
        "display" : "Analysis for antibody to HIV-2 virus"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "86703",
        "display" : "Analysis for antibody to HIV-1 and HIV-2 virus"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87389",
        "display" : "Detection test by immunoassay technique for HIV-1 antigen and HIV-1 and HIV-2 antibodies"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87390",
        "display" : "Detection test by immunoassay technique for HIV-1 antigen"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87391",
        "display" : "Detection test by immunoassay technique for HIV-2 antigen"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87534",
        "display" : "Detection test by nucleic acid for HIV-1 virus, direct probe technique"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87535",
        "display" : "Detection test by nucleic acid for HIV-1 virus, amplified probe technique"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87536",
        "display" : "Detection test by nucleic acid for HIV-1 virus, quantification"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87537",
        "display" : "Detection test by nucleic acid for HIV-2 virus, direct probe technique"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87538",
        "display" : "Detection test by nucleic acid for HIV-2 virus, amplified probe technique"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87539",
        "display" : "Detection test by nucleic acid for HIV-2 virus, quantification"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87900",
        "display" : "Infectious agent drug susceptibility analysis"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87901",
        "display" : "Analysis test by nucleic acid for HIV-1 virus"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87903",
        "display" : "Analysis test by nucleic acid for HIV-1 virus, first through 10 drugs tested"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87904",
        "display" : "Analysis test by nucleic acid for HIV-1 virus, each additional drug tested"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "87906",
        "display" : "Analysis test by nucleic acid for HIV-1 virus, other region"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G0432",
        "display" : "Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G0433",
        "display" : "Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G0435",
        "display" : "Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "S3645",
        "display" : "Hiv-1 antibody testing of oral mucosal transudate"
      }
    ]
  }
}
